Please login to the form below

Not currently logged in
Email:
Password:

CROS NT appoints Andrew MacGarvey to lead new UK office

Contract research organisation's new facility will be based in Milton Keynes

CROS NT Andrew MacGarveyItalian contract research organisation CROS NT has expanded into the UK and appointed Andrew MacGarvey to lead operations from its new facility in Milton Keynes.

MacGarvey has over 15 years' experience within the pharmaceutical sector and as CROS NT's new vice president of UK and USA operations he will be tasked with growing ties with the contract research organisation's UK-based customers.

MacGarvey previously held senior management and director roles at multiple contract research organisation (CROs) in Europe and the US.

"I have followed the activities of CROS NT for some time," MacGarvey said. "I am excited by the opportunity to help with the growth of the business. CROS NT are focused on customer care, something that is very important to me. I will be bringing their great service to the UK and ultimately the US."

Verona-headquartered CROS NT's new UK base joins its existing facilities in Italy and Augsburg, Germany.

17th August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Rock Unlimited

Rock Unlimited: Science as you've never seen it...

Latest intelligence

Webinar: How to conduct effective market research in emerging markets
Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge....
Webinar: Uncovering hidden insights into patient compliance
...
The patient journey: Time to look beyond the physician?
Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues....